Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06652100
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-10-04
Brief Title:
Establishment of ProNephro AKI NGAL Cut Off Value for Risk Assessment of Moderate to Severe Acute Kidney Injury in Adults
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Establishment of ProNephro AKI NGAL Cut Off Value for Risk Assessment of Moderate to Severe Acute Kidney Injury in Adults EPACRA-AKI
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
EPACRA-AKI
Brief Summary:
The purpose of this research is to collect blood and urine from adult patients admitted to an intensive care unit This is to assess the performance of the ProNephro AKI NGAL assay lab test as an aid to identify patients at risk for acute kidney injury
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None